IL283757A - Engineered products derived from flagellin and their uses - Google Patents

Engineered products derived from flagellin and their uses

Info

Publication number
IL283757A
IL283757A IL283757A IL28375721A IL283757A IL 283757 A IL283757 A IL 283757A IL 283757 A IL283757 A IL 283757A IL 28375721 A IL28375721 A IL 28375721A IL 283757 A IL283757 A IL 283757A
Authority
IL
Israel
Prior art keywords
derived compositions
flagellin
engineered
engineered flagellin
compositions
Prior art date
Application number
IL283757A
Other languages
English (en)
Hebrew (he)
Original Assignee
Genome Prot Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genome Prot Inc filed Critical Genome Prot Inc
Publication of IL283757A publication Critical patent/IL283757A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL283757A 2018-12-07 2021-06-06 Engineered products derived from flagellin and their uses IL283757A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862776507P 2018-12-07 2018-12-07
PCT/US2019/064954 WO2020118192A1 (en) 2018-12-07 2019-12-06 Engineered flagellin-derived compositions and uses

Publications (1)

Publication Number Publication Date
IL283757A true IL283757A (en) 2021-07-29

Family

ID=70974397

Family Applications (1)

Application Number Title Priority Date Filing Date
IL283757A IL283757A (en) 2018-12-07 2021-06-06 Engineered products derived from flagellin and their uses

Country Status (10)

Country Link
US (1) US20220024991A1 (cg-RX-API-DMAC7.html)
EP (1) EP3890769A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022511881A (cg-RX-API-DMAC7.html)
KR (1) KR20210111770A (cg-RX-API-DMAC7.html)
CN (1) CN113382742A (cg-RX-API-DMAC7.html)
AU (1) AU2019392903A1 (cg-RX-API-DMAC7.html)
CA (1) CA3122067A1 (cg-RX-API-DMAC7.html)
EA (1) EA202191610A1 (cg-RX-API-DMAC7.html)
IL (1) IL283757A (cg-RX-API-DMAC7.html)
WO (1) WO2020118192A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102720967B1 (ko) * 2020-06-04 2024-10-23 가톨릭대학교 산학협력단 플라젤린으로부터 유도된 tlr5 작용제를 유효성분으로 포함하는 면역관문억제제의 항암 효과 증진용 약학 조성물
CN119522108A (zh) * 2022-06-01 2025-02-25 弗莱格生物公司 Rna佐剂、其方法和用途
KR102896818B1 (ko) * 2022-10-19 2025-12-08 전남대학교 산학협력단 Tlr5 활성능을 가진 플라젤린 면역증강제 유도체의 진핵세포 발현시스템을 이용한 제조 및 응용
KR20240081501A (ko) * 2022-11-14 2024-06-10 전남대학교산학협력단 암의 치료용 면역증강 살모넬라 균주 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2121734B1 (en) * 2007-02-09 2013-05-08 Industry Foundation of Chonam National University Modified flagellin improved toll-like receptor 5 stimulating activity
US9376495B2 (en) * 2011-05-21 2016-06-28 Macrogenics, Inc. Deimmunized serum-binding domains and their use in extending serum half-life
CA2903252C (en) * 2013-03-14 2023-01-17 Research Corporation Technologies, Inc. Ribotoxin molecules derived from sarcin and other related fungal ribotoxins
EP3174893B1 (en) * 2014-07-30 2020-05-06 Genome Protection, Inc. Flagellin compositions and uses

Also Published As

Publication number Publication date
CA3122067A1 (en) 2020-06-11
US20220024991A1 (en) 2022-01-27
EA202191610A1 (ru) 2021-10-25
CN113382742A (zh) 2021-09-10
AU2019392903A1 (en) 2021-06-24
JP2022511881A (ja) 2022-02-01
EP3890769A4 (en) 2022-11-23
EP3890769A1 (en) 2021-10-13
KR20210111770A (ko) 2021-09-13
WO2020118192A1 (en) 2020-06-11

Similar Documents

Publication Publication Date Title
SG11202100071YA (en) Fusosome compositions and uses thereof
SG11202011015QA (en) Fusosome compositions and uses thereof
IL279755A (en) Senolytic preparations and their uses
SG11202000940XA (en) Glp-1 compositions and uses thereof
IL271275B1 (en) Preparations containing croons and their uses
IL277663A (en) Arunumab preparations and their uses
GB201812334D0 (en) Compositions and uses thereof
SG11202002224XA (en) Composition and uses thereof
GB201712592D0 (en) Novel compositions and uses thereof
IL279936A (en) Haloperoxidase preparations and their uses
GB201821138D0 (en) Compositions and uses thereof
GB201807576D0 (en) Compositions and uses thereof
GB201812952D0 (en) Compositions and uses thereof
PL3577266T3 (pl) Ulepszone kompozycje środków wiążących i ich zastosowania
HK40062246A (en) Engineered flagellin-derived compositions and uses
GB201821144D0 (en) Compositions and uses thereof
GB201819493D0 (en) Compositions and uses thereof
GB201818495D0 (en) Compositions and uses thereof
GB201818375D0 (en) Compositions and uses thereof
GB201907351D0 (en) Compositions and uses thereof
GB201905690D0 (en) Compositions and uses thereof
GB201905593D0 (en) Compositions and uses thereof
GB201904289D0 (en) Compositions and uses thereof
GB201904281D0 (en) Compositions and uses thereof
GB201902753D0 (en) Compositions and uses thereof